Erythromycin Tablet, Delayed Release
Product Images NDC 13668-586

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 13668-586). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Erythro250mg (Erythro250mg)

This is a prescription drug, made by Torrent Pharma Inc. and distributed by Appe Pharma LLC. The drug is in tablet form, with each container containing 100 tablets. The active ingredient is Erythromycin, a delayed-release drug that can be taken without regard to meals. The tablets need to be kept in a tightly sealed container at a temperature range of 20 to 25°C (68 to 77°F), with excursions permitted to 15 to 30°C (59 to 86°F). The usual dosage is not available and needs to be checked on the package insert.*

FDA Label Image

Erythro500mg (Erythro500mg)

This is a medication bottle containing 100 tablets. The medicine is Delayed-Release Ko oy g Tablets, USP R, and the usual dosage instructions can be found in the package insert. The medication should be stored between 20°C and 25°C. The manufacturer is Torrent Pharma Inc. and it was made for Appco Pharma LG. It is important to not accept the bottle if the seal is broken or missing.*

FDA Label Image

Torrentlogo (Torrentlogo)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.